Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection (Q34186933)

31 July 2017

title

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

1 reference

1 reference

11

Stefan Zeuzem

1 reference

31 July 2017

Mireen Friedrich-Rust

2

object named as

Mireen Friedrich-Rust

1 reference

31 July 2017

7

Jan Peveling-Oberhag

0 references

Heinfried H. Radeke

object named as

Heinfried H Radeke

8

0 references

Albrecht Piiper

13

object named as

Albrecht Piiper

1 reference

31 July 2017

Verena Bihrer

1

1 reference

31 July 2017

Bernd Kronenberger

3

1 reference

31 July 2017

Nicole Forestier

4

1 reference

31 July 2017

Jörg Haupenthal

5

1 reference

31 July 2017

Ying Shi

6

1 reference

31 July 2017

Jan Peveling-Oberhag

7

1 reference

31 July 2017

Christoph Sarrazin

9

1 reference

31 July 2017

Eva Herrmann

10

1 reference

31 July 2017

Oliver Waidmann

12

1 reference

31 July 2017

language of work or name

English

0 references

publication date

24 May 2011

1 reference

The American Journal of Gastroenterology

31 July 2017

published in

1 reference

31 July 2017

volume

106

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

1663-1669

1 reference

The functions of animal microRNAs

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

The diverse functions of microRNAs in animal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Identification of tissue-specific microRNAs from mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Plasma miR-208 as a biomarker of myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Export of microRNAs and microRNA-protective protein by mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Serum alanine aminotransferase in skeletal muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

The role of liver biopsy in hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

Serum hepatitis C virus titers in the progression of type C chronic liver disease. With special emphasis on patients with type 1b infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.161

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.161

1 reference

Dimensions Publication ID

31 July 2017

1022470665

0 references

1 reference